The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Role of chemokine RANTES in the regulation of perivascular inflammation, T‐cell accumulation, and vascular dysfunction in hypertension
Open accessAbstract
Recent studies have emphasized the role of perivascular inflammation in cardiovascular disease. We studied mechanisms of perivascular leukocyte infiltration in angiotensin II (Ang II)‐induced hypertension and their links to vascular dysfunction. Chronic Ang II infusion in mice increased immune cell content of T cells (255 ± 130 to 1664 ± 349 cells/mg; P < 0.01), M1 and M2 macrophages, and dendritic cells in perivascular adipose tissue. In particular, the content of T lymphocytes bearing CC chemokine receptor (CCR) 1, CCR3, and CCR5 receptors for RANTES chemokine was increased by Ang II (CCR1, 15.6 ± 1.5% vs. 31 ± 5%; P < 0.01). Hypertension was associated with an increase in perivascular adipose tissue expression of the chemokine RANTES (relative quantification, 1.2 ± 0.2 vs. 3.5 ± 1.1; P < 0.05), which induced T‐cell chemotaxis and vascular accumulation of T cells expressing the chemokine receptors CCR1, CCR3, and CCR5. Mechanistically, RANTES –/– knockout protected against vascular leukocyte, and in particular T lymphocyte infiltration (26 ± 5% in wild type Ang II vs. 15 ± 4% in RANTES –/– ), which was associated with protection from endothelial dysfunction induced by Ang II. This effect was linked with diminished infiltration of IFN‐γ‐producing CD8 + and double‐negative CD3 + CD4 – CD8 – T cells in perivascular space and reduced vascular oxidative stress while FoxP3 + T‐regulatory cells were unaltered. IFN‐γ ex vivo caused significant endothelial dysfunction, which was reduced by superoxide anion scavenging. In a human cohort, a significant inverse correlation was observed between circulating RANTES levels as a biomarker and vascular function measured as flow‐mediated dilatation ( R = –0.3, P < 0.01) or endothelial injury marker von Willebrand factor ( R = +0.3; P < 0.01). Thus, chemokine RANTES is important in the regulation of vascular dysfunction through modulation of perivascular inflammation.—Mikolajczyk, T. P., Nosalski, R., Szczepaniak, P., Budzyn, K., Osmenda, G., Skiba, D., Sagan, A., Wu, J., Vinh, A., Marvar, P. J., Guzik, B., Podolec, J., Drummond, G., Lob, H. E., Harrison, D. G., Guzik, T. J. Role of chemokine RANTES in the regulation of perivascular inflammation, T‐cell accumulation, and vascular dysfunction in hypertension. FASEB J. 30, 1987–1999 (2016). www.fasebj.org
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance
Vandanmagsar, B., Youm, Y.-H., Ravussin, A., Galgani, J. E., Stadler, K., Mynatt, R. L., Ravussin, E., Stephens, J. M., & Dixit, V. D. (2011) · Nature Medicine · doi:10.1038/nm.2279 · Cited by 2,655
Role of the T cell in the genesis of angiotensin II–induced hypertension and vascular dysfunction
Guzik, T. J., Hoch, N. E., Brown, K. A., McCann, L. A., Rahman, A., Dikalov, S., Goronzy, J., Weyand, C., & Harrison, D. G. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070657 · Cited by 1,736
Self-citationInterleukin 17 Promotes Angiotensin II–Induced Hypertension and Vascular Dysfunction
Madhur, M. S., Lob, H. E., McCann, L. A., Iwakura, Y., Blinder, Y., Guzik, T. J., & Harrison, D. G. (2010) · Hypertension · doi:10.1161/hypertensionaha.109.145094 · Cited by 827
Self-citationWu, H., Ghosh, S., Perrard, X. D., Feng, L., Garcia, G. E., Perrard, J. L., Sweeney, J. F., Peterson, L. E., Chan, L., Smith, C. W., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.638379 · Cited by 680
DC isoketal-modified proteins activate T cells and promote hypertension
Kirabo, A., Fontana, V., de Faria, A. P. C., Loperena, R., Galindo, C. L., Wu, J., Bikineyeva, A. T., Dikalov, S., Xiao, L., Chen, W., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci74084 · Cited by 538
Self-citationInterferon-γ, a Th1 Cytokine, Regulates Fat Inflammation: A Role for Adaptive Immunity in Obesity
Rocha, V. Z., Folco, E. J., Sukhova, G., Shimizu, K., Gotsman, I., Vernon, A. H., & Libby, P. (2008) · Circulation Research · doi:10.1161/circresaha.108.177105 · Cited by 523
Wenzel, P., Knorr, M., Kossmann, S., Stratmann, J., Hausding, M., Schuhmacher, S., Karbach, S. H., Schwenk, M., Yogev, N., Schulz, E., et al. (2011) · Circulation · doi:10.1161/circulationaha.111.034470 · Cited by 504
A human T cell-specific molecule is a member of a new gene family.
Schall, T. J., Jongstra, J., Dyer, B. J., Jorgensen, J., Clayberger, C., Davis, M. M., & Krensky, A. M. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.141.3.1018 · Cited by 495
Distribution and Development of Brown Adipocytes in the Murine and Human Adipose Organ
Frontini, A., & Cinti, S. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.03.004 · Cited by 459
T Regulatory Lymphocytes Prevent Angiotensin II–Induced Hypertension and Vascular Injury
Barhoumi, T., Kasal, D. A., Li, M. W., Shbat, L., Laurant, P., Neves, M. F., Paradis, P., & Schiffrin, E. L. (2011) · Hypertension · doi:10.1161/hypertensionaha.110.162941 · Cited by 459
Galkina, E., Kadl, A., Sanders, J., Varughese, D., Sarembock, I. J., & Ley, K. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052205 · Cited by 450
Koenen, R. R., von Hundelshausen, P., Nesmelova, I. V., Zernecke, A., Liehn, E. A., Sarabi, A., Kramp, B. K., Piccinini, A. M., Paludan, S. R., Kowalska, M. A., et al. (2009) · Nature Medicine · doi:10.1038/nm.1898 · Cited by 440
Targeting CCL5 in inflammation
Marques, R. E., Guabiraba, R., Russo, R. C., & Teixeira, M. M. (2013) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2013.837886 · Cited by 384
Antagonism of RANTES Receptors Reduces Atherosclerotic Plaque Formation in Mice
Veillard, N. R., Kwak, B., Pelli, G., Mulhaupt, F., James, R. W., Proudfoot, A. E. I., & Mach, F. (2004) · Circulation Research · doi:10.1161/01.res.0000109793.17591.4e · Cited by 377
Margaritis, M., Antonopoulos, A. S., Digby, J., Lee, R., Reilly, S., Coutinho, P., Shirodaria, C., Sayeed, R., Petrou, M., De Silva, R., et al. (2013) · Circulation · doi:10.1161/circulationaha.112.001133 · Cited by 361
Angiotensin II hypertension is attenuated in interleukin-6 knockout mice
Lee, D. L., Sturgis, L. C., Labazi, H., Osborne, J. B., Fleming, C., Pollock, J. S., Manhiani, M., Imig, J. D., & Brands, M. W. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00708.2005 · Cited by 254
Wolf, G., Ziyadeh, F. N., Thaiss, F., Tomaszewski, J., Caron, R. J., Wenzel, U., Zahner, G., Helmchen, U., & Stahl, R. A. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119615 · Cited by 253
Inflammation and Hypertension: New Understandings and Potential Therapeutic Targets
De Miguel, C., Rudemiller, N. P., Abais, J. M., & Mattson, D. L. (2015) · Current Hypertension Reports · doi:10.1007/s11906-014-0507-z · Cited by 215
Interferon-γ Signaling Inhibition Ameliorates Angiotensin II–Induced Cardiac Damage
Markó, L., Kvakan, H., Park, J.-K., Qadri, F., Spallek, B., Binger, K. J., Bowman, E. P., Kleinewietfeld, M., Fokuhl, V., Dechend, R., et al. (2012) · Hypertension · doi:10.1161/hypertensionaha.112.199265 · Cited by 184
Immune mechanisms in hypertension and vascular injury
Schiffrin, E. L. (2014) · Clinical Science · doi:10.1042/cs20130407 · Cited by 182
Mattson, D. L., Lund, H., Guo, C., Rudemiller, N., Geurts, A. M., & Jacob, H. (2013) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00304.2012 · Cited by 178
Kossmann, S., Schwenk, M., Hausding, M., Karbach, S. H., Schmidgen, M. I., Brandt, M., Knorr, M., Hu, H., Kröller-Schön, S., Schönfelder, T., et al. (2013) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.113.301437 · Cited by 163
Proinflammatory Phenotype of Perivascular Adipocytes
Omar, A., Chatterjee, T. K., Tang, Y., Hui, D. Y., & Weintraub, N. L. (2014) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.114.303030 · Cited by 160
Tumor Necrosis Factor-α Produced in the Kidney Contributes to Angiotensin II–dependent Hypertension
Zhang, J., Patel, M. B., Griffiths, R., Mao, A., Song, Y.-S., Karlovich, N. S., Sparks, M. A., Jin, H., Wu, M., Lin, E. E., et al. (2014) · Hypertension · doi:10.1161/hypertensionaha.114.03863 · Cited by 158
The Unexpected Pleiotropic Activities of RANTES
Levy, J. A. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0990015 · Cited by 156
Adrenergic Innervation of Adipose Tissue examined by Fluorescence Microscopy
Wirsén, C. (1964) · Nature · doi:10.1038/202913a0 · Cited by 156
CD247 Modulates Blood Pressure by Altering T-Lymphocyte Infiltration in the Kidney
Rudemiller, N. P., Lund, H., Jacob, H. J., Geurts, A. M., & Mattson, D. L. (2013) · Hypertension · doi:10.1161/hypertensionaha.113.02191 · Cited by 155
Lymphocyte adaptor protein LNK deficiency exacerbates hypertension and end-organ inflammation
Saleh, M. A., McMaster, W. G., Wu, J., Norlander, A. E., Funt, S. A., Thabet, S., Kirabo, A., Xiao, L., Chen, W., Itani, H. A., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci76327 · Cited by 153
Self-citationSex-Specific T-Cell Regulation of Angiotensin II–Dependent Hypertension
Ji, H., Zheng, W., Li, X., Liu, J., Wu, X., Zhang, M. A., Umans, J. G., Hay, M., Speth, R. C., Dunn, S. E., et al. (2014) · Hypertension · doi:10.1161/hypertensionaha.114.03663 · Cited by 142
Peng, X., Xiao, Z., Zhang, J., Li, Y., Dong, Y., & Du, J. (2014) · The Journal of Pathology · doi:10.1002/path.4430 · Cited by 137
Gao, Y.-J. (2007) · Current Pharmaceutical Design · doi:10.2174/138161207781039634 · Cited by 130
Pons, H., Ferrebuz, A., Quiroz, Y., Romero-Vásquez, F., Parra, G., Johnson, R. J., & Rodríguez‐Iturbe, B. (2012) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00517.2012 · Cited by 104
Mateo, T., Nabah, Y. N. A., Abu-Taha, M. I., Mata, M., Cerdá‐Nicolás, M., Proudfoot, A. E. I., Stahl, R. A. K., Issekutz, A. C., Cortijo, J., Morcillo, E. J., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.9.5577 · Cited by 98
Crowley, S. D., Song, Y.-S., Sprung, G. M., Griffiths, R., Sparks, M. A., Yan, M., Burchette, J. L., Howell, D. N., Lin, E. E., Okeiyi, B., et al. (2009) · Hypertension · doi:10.1161/hypertensionaha.109.144964 · Cited by 86
Li, Y., Wu, Y., Zhang, C., Li, P., Cui, W., Hao, J., Ma, X., Yin, Z., & Du, J. (2014) · Hypertension · doi:10.1161/hypertensionaha.113.02604 · Cited by 85
Alterations in perivascular adipose tissue structure and function in hypertension
Lü, C., Su, L.-Y., Lee, R. M. K. W., & Gao, Y.-J. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.01.023 · Cited by 84
Elevated Blood Pressure in Transgenic Lipoatrophic Mice and Altered Vascular Function
Takemori, K., Gao, Y., Ding, L., Lü, C., Su, L.-Y., An, W.-S., Vinson, C., & Lee, R. M. K. W. (2007) · Hypertension · doi:10.1161/01.hyp.0000255576.16089.b9 · Cited by 73
Adipose‐derived protein omentin prevents neointimal formation after arterial injury
Uemura, Y., Shibata, R., Kanemura, N., Ohashi, K., Kambara, T., Hiramatsu‐Ito, M., Enomoto, T., Yuasa, D., Joki, Y., Matsuo, K., et al. (2014) · The FASEB Journal · doi:10.1096/fj.14-258129 · Cited by 70
Novel role for retinol-binding protein 4 in the regulation of blood pressure
Kraus, B. J., Sartoretto, J. L., Polak, P., Hosooka, T., Shiroto, T., Eskurza, I., Lee, S., Jiang, H., Michel, T. M., & Kahn, B. B. (2015) · The FASEB Journal · doi:10.1096/fj.14-266064 · Cited by 49
C/ EBP transcription factors regulate NADPH oxidase in human aortic smooth muscle cells
Manea, S., Todirita, A., Raicu, M., & Manea, A. (2014) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12289 · Cited by 47
Agrewala, J. N., Brown, D. M., Lepak, N. M., Duso, D. K., Huston, G. E., & Swain, S. L. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m608266200 · Cited by 32
Wołkow, P. P., Kosiniak-Kamysz, W., Osmenda, G., Wilk, G., Bujak-Giżycka, B., Ignacak, A., Kanitkar, M., Waluś‐Miarka, M., Harrison, D. G., Korbut, R., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108587 · Cited by 14
Self-citation
Cited by
Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology
Forrester, S. J., Booz, G. W., Sigmund, C. D., Coffman, T. M., Kawai, T., Rizzo, V., Scalia, R., & Eguchi, S. (2018) · Physiological Reviews · doi:10.1152/physrev.00038.2017 · Cited by 1,095
Oxidative Stress, Inflammation, and Vascular Aging in Hypertension
Guzik, T. J., & Touyz, R. M. (2017) · Hypertension · doi:10.1161/hypertensionaha.117.07802 · Cited by 766
Self-citationXiao, L., & Harrison, D. G. (2020) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2020.01.013 · Cited by 545
Self-citationThe role of adipose tissue in cardiovascular health and disease
Oikonomou, E. K., & Antoniades, C. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0097-6 · Cited by 504
The role of infiltrating immune cells in dysfunctional adipose tissue
Guzik, T. J., Skiba, D. S., Touyz, R. M., & Harrison, D. G. (2017) · Cardiovascular Research · doi:10.1093/cvr/cvx108 · Cited by 445
Self-citation
Metadata
- Authors
- Mikolajczyk, T. P., Nosalski, R., Szczepaniak, P., Budzyn, K., Osmenda, G., Skiba, D., Sagan, A., Wu, J., Vinh, A., Marvar, P. J., Guzik, B., Podolec, J., Drummond, G., Lob, H. E., Harrison, D. G., & Guzik, T. J.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2016-02-12
- Volume
- 30
- Issue
- 5
- Pages
- 1987-1999
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2337180881
- Cited by
- 253
- References
- 42
- FWCI
- 17.18
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.